EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Challenges and innovations in CAR-T cell therapy: a comprehensive analysis

Jingming Luo, Xianwen Zhang

Frontiers in Oncology · 11.06.2024 · 14

DOI: 10.3389/fonc.2024.1399544 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 11.06.2024. Verfasst von Jingming Luo und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent years have seen a marked increase in research on chimeric antigen receptor T (CAR-T) cells, with specific relevance to the treatment of hematological malignancies. Here, the structural principles, iterative processes, and target selection of CAR-T cells for therapeutic applications are described in detail, as well as the challenges faced in the treatment of solid tumors and hematological malignancies. These challenges include insufficient infiltration of cells, off-target effects, cytokine release syndrome, and tumor lysis syndrome. In addition, directions in the iterative development of CAR-T cell therapy are discussed, including modifications of CAR-T cell structures, improvements in specificity using multi-targets and novel targets, the use of Boolean logic gates to minimize off-target effects and control toxicity, and the adoption of additional protection mechanisms to improve the durability of CAR-T cell treatment. This review provides ideas and strategies for the development of CAR-T cell therapy through an in-depth exploration of the underlying mechanisms of action of CAR-T cells and their potential for innovative modification.

Schlagwörter

Stichwörter der Autor:innen

Boolean logic gate strategyCAR-NK therapyCAR-T therapyCRSTME

Autor:innen und Institutionen

  • College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Luo, J., & Zhang, X. (2024). Challenges and innovations in CAR-T cell therapy: a comprehensive analysis. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1399544

Vancouver

Luo J, Zhang X. Challenges and innovations in CAR-T cell therapy: a comprehensive analysis. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1399544

BibTeX
@article{Luo2024,
  author = {Luo, Jingming and Zhang, Xianwen},
  title = {Challenges and innovations in CAR-T cell therapy: a comprehensive analysis},
  journal = {Frontiers in Oncology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fonc.2024.1399544}
}
Kostenlos starten →